• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔鳞状细胞癌中β-连环蛋白差异表达与Oct-4和Nanog的相关性及其与临床病理因素和预后的关系

Association of differential β-catenin expression with Oct-4 and Nanog in oral squamous cell carcinoma and their correlation with clinicopathological factors and prognosis.

作者信息

Ravindran Gokulan, Sawant Sharada S, Hague Angela, Kingsley Karl, Devaraj Halagowder

机构信息

Unit of Biochemistry, Department of Zoology, University of Madras, Guindy Campus, Chennai, Tamil Nadu, India.

Cancer Research Institute, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai, India.

出版信息

Head Neck. 2015 Jul;37(7):982-93. doi: 10.1002/hed.23699. Epub 2014 Jun 27.

DOI:10.1002/hed.23699
PMID:24700702
Abstract

BACKGROUND

The re-expression of pluripotent markers (Oct-4 and Nanog) and the reactivation of stem cell-related pathways in oral carcinoma have been well researched. However, the relationship between the stem cell signaling molecule β-catenin and pluripotent markers Oct-4 and Nanog in oral cancer is yet to be studied in detail. Therefore, we have investigated the correlation among Oct-4, Nanog, and β-catenin in oral squamous cell carcinoma, which, in turn, could provide valuable insight into its prognostic significance.

METHODS

The immunohistochemical analysis was performed for 60 cases of oral cancer to study the expression pattern of Oct-4, Nanog, and β-catenin. Whereas immunofluorescence analysis was used to investigate the co-localization of β-catenin with Oct-4 and Nanog in oral carcinoma tissues and H314 cell line. Finally, co-immunoprecipitation analysis was used to study the possible interaction between β-catenin and Oct-4 in oral carcinoma cells.

RESULTS

β-catenin, Oct-4, and Nanog showed significant correlation with lymph node metastasis, stage, grade, and prognosis in oral squamous cell carcinoma. Interestingly, a significant positive correlation was found among the expression of Oct-4, Nanog, and β-catenin. Moreover, the interaction between β-catenin and Oct-4 was observed in oral cancer.

CONCLUSION

The positive correlation among Oct-4, Nanog, and β-catenin suggests their coordinated role in maintaining proliferation in oral carcinoma cells. The interaction between β-catenin and Oct-4 may be a crucial event in oral carcinogenesis. On the other hand, β-catenin, Oct-4, and Nanog could be used as independent prognostic markers of oral squamous cell carcinoma.

摘要

背景

口腔癌中多能性标志物(Oct-4和Nanog)的重新表达以及干细胞相关通路的重新激活已得到充分研究。然而,口腔癌中干细胞信号分子β-连环蛋白与多能性标志物Oct-4和Nanog之间的关系尚待详细研究。因此,我们研究了口腔鳞状细胞癌中Oct-4、Nanog和β-连环蛋白之间的相关性,这反过来可能为其预后意义提供有价值的见解。

方法

对60例口腔癌进行免疫组织化学分析,以研究Oct-4、Nanog和β-连环蛋白的表达模式。而免疫荧光分析则用于研究β-连环蛋白与Oct-4和Nanog在口腔癌组织和H314细胞系中的共定位。最后,采用免疫共沉淀分析研究口腔癌细胞中β-连环蛋白与Oct-4之间可能的相互作用。

结果

β-连环蛋白、Oct-4和Nanog与口腔鳞状细胞癌的淋巴结转移、分期、分级和预后显著相关。有趣的是,Oct-4、Nanog和β-连环蛋白的表达之间存在显著正相关。此外,在口腔癌中观察到β-连环蛋白与Oct-4之间的相互作用。

结论

Oct-4、Nanog和β-连环蛋白之间的正相关表明它们在维持口腔癌细胞增殖中起协同作用。β-连环蛋白与Oct-4之间的相互作用可能是口腔癌发生中的关键事件。另一方面,β-连环蛋白、Oct-4和Nanog可作为口腔鳞状细胞癌的独立预后标志物。

相似文献

1
Association of differential β-catenin expression with Oct-4 and Nanog in oral squamous cell carcinoma and their correlation with clinicopathological factors and prognosis.口腔鳞状细胞癌中β-连环蛋白差异表达与Oct-4和Nanog的相关性及其与临床病理因素和预后的关系
Head Neck. 2015 Jul;37(7):982-93. doi: 10.1002/hed.23699. Epub 2014 Jun 27.
2
Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.Oct3/4和Nanog在头颈部鳞状癌细胞中的表达及其对I/II期口腔舌鳞状细胞癌颈部延迟转移的临床意义。
BMC Cancer. 2015 Oct 19;15:730. doi: 10.1186/s12885-015-1732-9.
3
Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.口腔癌干细胞和高级别口腔鳞状细胞癌中Oct-4与Nanog的正相关性。
Clin Cancer Res. 2008 Jul 1;14(13):4085-95. doi: 10.1158/1078-0432.CCR-07-4404.
4
Aberrant expression of β-catenin and its association with ΔNp63, Notch-1, and clinicopathological factors in oral squamous cell carcinoma.口腔鳞状细胞癌中β-连环蛋白的异常表达及其与ΔNp63、Notch-1 和临床病理因素的关系。
Clin Oral Investig. 2012 Aug;16(4):1275-88. doi: 10.1007/s00784-011-0605-0. Epub 2011 Sep 1.
5
Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.OCT4、SOX2和NANOG表达与口腔鳞状细胞癌进展的相关性
J Oral Pathol Med. 2016 Feb;45(2):89-95. doi: 10.1111/jop.12335. Epub 2015 Jul 25.
6
Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue.OCT4、SOX2和NANOG在口腔鳞状细胞癌与癌旁非肿瘤组织中的相对表达
Asian Pac J Cancer Prev. 2019 Jun 1;20(6):1649-1654. doi: 10.31557/APJCP.2019.20.6.1649.
7
Midkine and NANOG Have Similar Immunohistochemical Expression Patterns and Contribute Equally to an Adverse Prognosis of Oral Squamous Cell Carcinoma.中期因子和 NANOG 具有相似的免疫组织化学表达模式,对口腔鳞状细胞癌的不良预后具有同等贡献。
Int J Mol Sci. 2017 Nov 6;18(11):2339. doi: 10.3390/ijms18112339.
8
Induced Pluripotent-stem-cell Related Genes Contribute to De-differentiation in Oral Squamous Cell Carcinoma.诱导多能干细胞相关基因促成口腔鳞状细胞癌的去分化。
Anticancer Res. 2017 Mar;37(3):1075-1082. doi: 10.21873/anticanres.11419.
9
Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma.NANOG、突变型p53和CD44的阳性表达与口腔鳞状细胞癌的临床病理特征及不良预后直接相关。
BMC Oral Health. 2015 Dec 1;15(1):153. doi: 10.1186/s12903-015-0120-9.
10
Prognostic value of cathepsin L and its inhibitor headpin in oral squamous cell carcinoma.组织蛋白酶L及其抑制剂头蛋白在口腔鳞状细胞癌中的预后价值。
J Laryngol Otol. 2012 Nov;126(11):1134-7. doi: 10.1017/S0022215112001995. Epub 2012 Sep 11.

引用本文的文献

1
[Cancer stem cells in oral squamous cell carcinoma. Literature review].[口腔鳞状细胞癌中的癌症干细胞。文献综述]
Rev Cient Odontol (Lima). 2022 Jun 27;10(2):e106. doi: 10.21142/2523-2754-1002-2022-106. eCollection 2022 Apr-Jun.
2
OCT4's role and mechanism underlying oral squamous cell carcinoma.OCT4在口腔鳞状细胞癌中的作用及潜在机制。
J Zhejiang Univ Sci B. 2023;24(9):796-806. doi: 10.1631/jzus.B2200602.
3
Estrogen-Related Receptor Alpha (ERRα) Promotes Cancer Stem Cell-Like Characteristics in Breast Cancer.雌激素相关受体α(ERRα)促进乳腺癌中癌症干细胞样特征。
Stem Cell Rev Rep. 2023 Nov;19(8):2807-2819. doi: 10.1007/s12015-023-10605-2. Epub 2023 Aug 16.
4
High NANOG expression correlates with worse patients' survival in esophageal adenocarcinoma.高 NANOG 表达与食管腺癌患者的生存预后不良相关。
BMC Cancer. 2023 Jul 17;23(1):669. doi: 10.1186/s12885-023-11146-0.
5
Prognostic and Clinicopathological Significance of the Aberrant Expression of β-Catenin in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.β-连环蛋白异常表达在口腔鳞状细胞癌中的预后及临床病理意义:一项系统评价和Meta分析
Cancers (Basel). 2022 Jan 18;14(3):479. doi: 10.3390/cancers14030479.
6
Stem Cell Markers CXCR-4 and CD133 Predict Aggressive Phenotype and Their Double Positivity Indicates Poor Prognosis of Oral Squamous Cell Carcinoma.干细胞标志物CXCR - 4和CD133预示侵袭性表型,二者双阳性表明口腔鳞状细胞癌预后不良。
Cancers (Basel). 2021 Nov 23;13(23):5895. doi: 10.3390/cancers13235895.
7
Heterogeneity of Cancer Stem Cells in Tumorigenesis, Metastasis, and Resistance to Antineoplastic Treatment of Head and Neck Tumours.头颈部肿瘤发生、转移及抗肿瘤治疗耐药中的肿瘤干细胞异质性。
Cells. 2021 Nov 8;10(11):3068. doi: 10.3390/cells10113068.
8
MicroRNAs and Long Non-Coding RNAs as Regulators of NANOG Expression in the Development of Oral Squamous Cell Carcinoma.微小RNA和长链非编码RNA作为口腔鳞状细胞癌发生发展过程中NANOG表达的调节因子
Front Oncol. 2021 Feb 11;10:579053. doi: 10.3389/fonc.2020.579053. eCollection 2020.
9
Diagnostic significance and carcinogenic mechanism of pan-cancer gene POU5F1 in liver hepatocellular carcinoma.POU5F1 基因在肝癌中的多癌种诊断意义及其致癌机制。
Cancer Med. 2020 Dec;9(23):8782-8800. doi: 10.1002/cam4.3486. Epub 2020 Sep 26.
10
Alternation of β-catenin and CD44s Immunoexpression in Different Histopathological Grades of Oral Squamous Cell Carcinoma.β-连环蛋白和 CD44s 在口腔鳞状细胞癌不同组织学分级中的免疫表达改变。
Asian Pac J Cancer Prev. 2020 May 1;21(5):1181-1185. doi: 10.31557/APJCP.2020.21.5.1181.